176 related articles for article (PubMed ID: 31787246)
21. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
22. Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study.
Lupini L; Scutiero G; Iannone P; Martinello R; Bassi C; Ravaioli N; Soave I; Bonaccorsi G; Lanza G; Gafà R; Loizzi V; Negrini M; Greco P
Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13137. PubMed ID: 31412428
[TBL] [Abstract][Full Text] [Related]
23. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
24. Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation.
Suehiro Y; Okada T; Okada T; Anno K; Okayama N; Ueno K; Hiura M; Nakamura M; Kondo T; Oga A; Kawauchi S; Hirabayashi K; Numa F; Ito T; Saito T; Sasaki K; Hinoda Y
Clin Cancer Res; 2008 Jun; 14(11):3354-61. PubMed ID: 18519763
[TBL] [Abstract][Full Text] [Related]
25. Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer.
Erickson BK; Kinde I; Dobbin ZC; Wang Y; Martin JY; Alvarez RD; Conner MG; Huh WK; Roden RBS; Kinzler KW; Papadopoulos N; Vogelstein B; Diaz LA; Landen CN
Obstet Gynecol; 2014 Nov; 124(5):881-885. PubMed ID: 25437714
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation markers for endometrial cancer detection in minimally invasive samples: a systematic review.
den Helder RV; Wever BM; van Trommel JA; Ket JC; Bleeker MC; Steenbergen RD; van Trommel NE
Epigenomics; 2020 Sep; 12(18):1661-1672. PubMed ID: 32938224
[No Abstract] [Full Text] [Related]
27. Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer.
Ying J; Xu T; Wang Q; Ye J; Lyu J
Epigenetics; 2018; 13(5):490-504. PubMed ID: 29912667
[TBL] [Abstract][Full Text] [Related]
28. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
Cuevas D; Valls J; Gatius S; Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X
Virchows Arch; 2019 May; 474(5):585-598. PubMed ID: 30710169
[TBL] [Abstract][Full Text] [Related]
29. Gene Promoter Methylation in Endometrial Carcinogenesis.
Cornel KMC; Wouters K; Van de Vijver KK; van der Wurff AAM; van Engeland M; Kruitwagen RFPM; Pijnenborg JMA
Pathol Oncol Res; 2019 Apr; 25(2):659-667. PubMed ID: 30430425
[TBL] [Abstract][Full Text] [Related]
30. Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability.
Haruma T; Nagasaka T; Nakamura K; Haraga J; Nyuya A; Nishida T; Goel A; Masuyama H; Hiramatsu Y
PLoS One; 2018; 13(4):e0195655. PubMed ID: 29659608
[TBL] [Abstract][Full Text] [Related]
31. Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.
Martinez-Garcia E; Lesur A; Devis L; Cabrera S; Matias-Guiu X; Hirschfeld M; Asberger J; van Oostrum J; Casares de Cal MLÁ; Gómez-Tato A; Reventos J; Domon B; Colas E; Gil-Moreno A
Clin Cancer Res; 2017 Nov; 23(21):6458-6467. PubMed ID: 28790116
[No Abstract] [Full Text] [Related]
32. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine.
van den Helder R; Wever BMM; van Trommel NE; van Splunter AP; Mom CH; Kasius JC; Bleeker MCG; Steenbergen RDM
Clin Epigenetics; 2020 Nov; 12(1):165. PubMed ID: 33143739
[TBL] [Abstract][Full Text] [Related]
33. Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
Hoang LN; Kinloch MA; Leo JM; Grondin K; Lee CH; Ewanowich C; Köbel M; Cheng A; Talhouk A; McConechy M; Huntsman DG; McAlpine JN; Soslow RA; Gilks CB
Am J Surg Pathol; 2017 Feb; 41(2):245-252. PubMed ID: 28079598
[TBL] [Abstract][Full Text] [Related]
34. The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.
Beinse G; Just PA; Rance B; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Pasmant E; Batteux F; Borghese B; Alexandre J; Leroy K
PLoS One; 2019; 14(3):e0214416. PubMed ID: 30908539
[TBL] [Abstract][Full Text] [Related]
35. GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer.
Doufekas K; Hadwin R; Kandimalla R; Jones A; Mould T; Crowe S; Olaitan A; Macdonald N; Fiegl H; Wik E; Salvesen HB; Widschwendter M
Int J Gynecol Cancer; 2013 Jul; 23(6):1050-5. PubMed ID: 23727823
[TBL] [Abstract][Full Text] [Related]
36. Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma.
Sheng Y; Wang H; Liu D; Zhang C; Deng Y; Yang F; Zhang T; Zhang C
Gynecol Oncol; 2016 Jan; 140(1):145-51. PubMed ID: 26597461
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndrome.
Woolderink JM; De Bock GH; van Hemel BM; Geuken E; Hollema H; Werner N; Mourits MJ
BMC Womens Health; 2020 Mar; 20(1):54. PubMed ID: 32183830
[TBL] [Abstract][Full Text] [Related]
38. Atypical glandular cells of undetermined significance favor endometrial origin. Criteria for separating low grade endometrial adenocarcinoma from benign endometrial lesions.
Salomão DR; Hughes JH; Raab SS
Acta Cytol; 2002; 46(3):458-64. PubMed ID: 12040637
[TBL] [Abstract][Full Text] [Related]
39. Quantifying procedural pain associated with office gynecologic tract sampling methods.
Bagaria M; Wentzensen N; Clarke M; Hopkins MR; Ahlberg LJ; Mc Guire LJ; Lemens MA; Weaver AL; VanOosten A; Shields E; Laughlin-Tommaso SK; Sherman ME; Bakkum-Gamez JN
Gynecol Oncol; 2021 Jul; 162(1):128-133. PubMed ID: 33958213
[TBL] [Abstract][Full Text] [Related]
40. Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions.
Guida M; Sanguedolce F; Bufo P; Di Spiezio Sardo A; Bifulco G; Nappi C; Pannone G
Eur J Gynaecol Oncol; 2009; 30(3):267-70. PubMed ID: 19697618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
